By Dr. Daniel Jinhag Baik, MD, ophthalmologist and head director, Nunehim Eye Center (눈에힘안과의원), Guro-gu, Seoul. Educational article based on published studies and NICE guidance, November 2026.

If you live with diabetes and your vision has gone cloudy, you’ve probably heard warnings about cataract surgery. The questions I get most in clinic are: “Is surgery riskier because I’m diabetic?” “Does my HbA1c have to be under 7% first?” “Will surgery make my diabetic retinopathy worse?”

Short answer: Diabetes doesn’t rule out cataract surgery, and the operation itself is the same. What changes is the planning. The biggest diabetes-specific risk is swelling of the macula (the center of the retina) in the months after surgery. In a UK database of 81,984 eyes, that risk was about 1.8 times higher with diabetes alone and about 6.2 times higher with any diabetic retinopathy. Meanwhile, two large 2025 studies found that HbA1c on its own wasn’t linked to infection risk after cataract surgery. So the retina, not a single blood-sugar number, should set the plan: check it before surgery, and watch the macula closely for the first 3–6 months afterward.

Can you have cataract surgery if you have diabetes?

Yes. Diabetes is a reason to check the retina more carefully, not a reason to avoid surgery.

A cataract is a clouding of the eye’s natural lens. Surgery removes it and puts in an artificial intraocular lens (IOL). With diabetes, the technique doesn’t change.

Surgery can even help diabetes care. A dense cataract makes it hard for your doctor to see the retina, and diabetic retinopathy is a disease that needs regular retinal checks. A clear view back there is worth something.

Benefits for an eye with diabetes Trade-offs to plan for
Clearer vision for daily life, work and driving Higher risk of macular swelling after surgery
Easier retinal exams and treatment afterward Retinopathy may progress somewhat on average, so follow-up should be closer
Same surgical technique as for anyone else Final vision can be limited by the retina, even if surgery goes well

Why is macular edema the main concern?

After any cataract surgery, inflammation can make the macula swell. Diabetes weakens the tiny retinal blood vessels, so they leak more easily under that stress.

The macula handles sharp central vision: reading, faces, your screen. When fluid builds up there, vision can look blurry or wavy even though the cataract operation itself went perfectly.

Chu et al., 2016 (Ophthalmology). A retrospective study of electronic records from 8 UK sites covering 81,984 eyes operated on between 2010 and 2014. It counted new macular edema within 90 days. Eyes given preventive anti-inflammatory (NSAID) drops were excluded.

Group Macular edema after surgery
No complications, no diabetes, no other risk factors 1.17% (baseline)
Diabetes, no retinopathy About 1.8× baseline risk
Any diabetic retinopathy About 6.2× baseline risk

What this doesn’t mean: “6.2 times” is a relative risk on top of a baseline of roughly 1%. It doesn’t mean one in six people with retinopathy will get edema. Risk rose with retinopathy severity.

How much does retinopathy stage matter?

A lot. With moderate or severe non-proliferative retinopathy, about 1 in 10 eyes needed treatment for macular edema within a year, and the peak came 3–6 months after surgery.

Denniston et al., 2017 (British Journal of Ophthalmology). 4,850 eyes of people with diabetes, across 19 UK centers, with no macular edema before the study. In the same eyes, treatment-requiring edema rose from 2.9% in the year before surgery to 5.3% in the year after.

Retinopathy before surgery Treatment-requiring macular edema within 1 year
None 1.0%
Mild non-proliferative 5.4%
Moderate non-proliferative 10.0%
Severe non-proliferative 13.1%
Proliferative 4.9%

The annualized rate peaked at 6.8% in months 3–6. The lower figure for proliferative disease can’t be explained from the abstract alone, so please don’t read it as “advanced disease is safe.”

Does cataract surgery make diabetic retinopathy worse?

On average, somewhat. A 2025 meta-analysis found moderate evidence of faster progression, so closer retinal checks in the first year are sensible.

Lee et al., 2025 (American Journal of Ophthalmology). 15 studies, 7,287 patients.

  • Retinopathy progression: risk ratio 1.46
  • Progression to sight-threatening disease (macular edema or proliferative retinopathy): risk ratio 1.84
  • New retinopathy: risk ratio 1.38 overall, but no significant difference in studies comparing a person’s two eyes

What this doesn’t mean: it doesn’t prove surgery causes retinopathy. People who need surgery may already differ in diabetes duration or control. Interestingly, HbA1c, diabetes duration and insulin use didn’t significantly change the risk in this analysis.

Does my HbA1c have to hit a target first?

There’s no well-supported HbA1c cut-off for cataract surgery. In large 2025 studies, HbA1c wasn’t significantly linked to infection after surgery.

Many people assume cataract surgery works like other operations, where you need to get under a sugar target first. Recent data suggest it’s different.

Armbrust et al., 2025 (Ophthalmology). 190,393 US veterans with diabetes. Acute endophthalmitis (infection inside the eye) occurred in 157 (0.08%), and preoperative HbA1c wasn’t associated with it. The authors noted that HbA1c thresholds borrowed from non-eye surgery may not apply.

Hussain et al., 2025 (American Journal of Ophthalmology). Across HbA1c bands from under 7% to over 11.3%, 30-day infection and serious systemic events (death, stroke, major cardiac events) didn’t differ significantly from controls. Their conclusion: HbA1c alone shouldn’t be the reason to defer surgery.

That doesn’t mean blood sugar is irrelevant:

  • Diabetes itself carried a small increase in infection risk in Taiwan’s national data (883,398 patients: 0.261% vs 0.242% without diabetes).
  • A single-center retrospective study of 780 patients (Cui, 2026) linked HbA1c above 9% with slower visual recovery and more macular edema at 3 months.
  • A small retrospective study (Wang, 2026) reported more complications after rapid sugar lowering in the weeks before surgery. That’s low-quality evidence, but it’s a reason not to crash-diet your numbers to meet a surgery date.

In practice, the surgery date should come from your eye findings plus your physician’s view of your overall health, not one lab value.

Can macular edema be prevented?

It can be made less likely, not ruled out. For people with diabetes, guidelines suggest considering steroid drops plus NSAID drops after surgery. How much that protects final vision is still uncertain.

The UK’s NICE cataract guideline (NG77, recommendation 1.8.7) says to consider topical steroids combined with NSAIDs after surgery for people at higher risk of macular edema, such as people with diabetes.

ESCRS PREMED, 2018 (randomized trial, 213 patients with diabetes, 12 European centers). Everyone used steroid and NSAID drops. Adding a steroid injection under the conjunctiva at the end of surgery left the macula 12.3 µm and 9.7 µm thinner at 6 and 12 weeks, and no one in that group developed macular edema. An anti-VEGF injection into the eye had no significant effect.

Cochrane review, 2016 (34 trials, over 5,000 people). Adding NSAID drops to steroid drops lowered the risk of macular edema at 3 months (risk ratio 0.40), but the certainty was low, and the effect on actual vision was unclear. Stinging or burning was the most consistent side effect.

What this doesn’t mean: less swelling on a scan isn’t the same as better final vision. And depot steroid injections can raise eye pressure in some people (Laursen 2019 meta-analysis), so they’re not a one-size-fits-all add-on.

What if I already have retinopathy or macular edema?

The usual principle is to stabilize the retina first. Active macular edema is generally treated before, or timed with, cataract surgery.

A 2024 meta-analysis of randomized trials (Wu et al.) found that in people with existing retinopathy, anti-VEGF injections around the time of surgery lowered the risk of progression (risk ratio 0.37). The trials were small. And in PREMED, preventive anti-VEGF in eyes without edema didn’t help. So these injections are a treatment decision for eyes that need them, not a routine extra for everyone with diabetes.

Situation Usual direction
Diabetes, no retinopathy, cataract affecting daily life Standard surgical plan plus macular follow-up
Mild to moderate non-proliferative retinopathy OCT before surgery, a preventive drop plan, closer follow-up for 3–6 months
Severe non-proliferative or proliferative retinopathy Review retinal treatment status first, then time surgery
Current macular edema Often treat the edema first
Cataract too dense to examine the retina Consider earlier surgery so the retina can be monitored

General principles only; your plan depends on your exam.

Can I still choose a multifocal lens?

Not automatically excluded, but the evidence is limited, and a stable macula is the starting point.

Multifocal IOLs split light between focal points, which has raised concerns about lower contrast in eyes with retinal disease. A 2020 review (Grzybowski et al.) found no evidence that people with retinal disease should be told to avoid them, while calling for more research. A 2025 retrospective study of 138 patients with non-proliferative retinopathy (Liu et al.) found better near and intermediate vision with multifocal lenses, with higher-order aberrations a concern in some eyes.

If you’ve had macular edema or your retinopathy is progressing, a monofocal lens is often the more conservative choice, because you may need retinal treatment in the future. No lens can guarantee you’ll never need glasses.

What we check before surgery at Nunehim Eye Center

  1. Dilated retinal exam to stage diabetic retinopathy.
  2. Macular OCT scan to look for swelling you can’t see or feel yet.
  3. Your diabetes details: how long you’ve had it, recent HbA1c, insulin use, blood pressure and kidney function.
  4. Past retinal treatment: laser or injections, when and how many.
  5. Biometry and corneal measurements for lens power.
  6. Tear film check, because an unstable tear film makes measurements less reliable.

If the retina needs attention first, I’ll tell you that before we talk about lenses. I offer one-on-one consultations in English myself, so there’s no interpreter in the room.

Practical tips if you work in Guro or Gasan Digital Complex

  • Bring your numbers. Your latest HbA1c, fasting glucose from a company health check, and a medication list speed things up.
  • Book the 3–6 month visits early. That’s when edema peaks, so put them in your calendar before a busy project lands.
  • Set drop alarms. Anti-inflammatory drops often run for several weeks.
  • Don’t wait on warning signs. If your vision gets blurry again after improving, or straight lines on your screen look bent, come in before your scheduled visit.
  • Don’t change diabetes medicines on your own around surgery. Ask your physician.

Frequently asked questions

Is cataract surgery less successful in people with diabetes?
Many people with no or mild retinopathy do very well. With advanced retinopathy, the retina can limit how much vision improves, even after a perfect operation.

My HbA1c is 8%. Will I be turned away?
Not on that number alone. Large 2025 studies found HbA1c wasn’t significantly linked to infection after cataract surgery. Good control still matters for your retina and general health, so we plan with your physician.

When does macular edema usually appear?
In the UK data, treatment-requiring edema peaked 3–6 months after surgery. Vision can be fine at first and then blur weeks to months later.

Do the preventive drops guarantee no swelling?
No. They lower the risk, with low-certainty evidence, and their effect on final vision is unclear.

Do I need an eye injection before surgery?
Not routinely. In the PREMED trial, preventive anti-VEGF didn’t help eyes without edema. It’s considered when edema or significant retinopathy is already present.

Can I have both eyes done on the same day?
With diabetes, especially with retinopathy, seeing how the first eye’s macula responds before doing the second is often the more cautious plan. We decide this individually.

Will surgery definitely worsen my retinopathy?
No. Average progression risk was about 1.5 times higher in the 2025 meta-analysis, but that’s a population average. Closer checks in the first year catch changes early.

Does diabetes raise infection risk a lot?
Only slightly in large data (0.261% vs 0.242% in Taiwan). Severe pain or a sudden drop in vision after surgery needs same-day attention.

Bottom line

Diabetes doesn’t stop you from having cataract surgery, and one HbA1c value is a weak reason to delay it. What matters more is your retina: check and stabilize it before surgery, use the anti-inflammatory plan your surgeon recommends, and keep your 3–6 month follow-ups, when macular swelling is most likely.

If you’d like to read more on cataracts: When should you have cataract surgery?, Cloudy vision after cataract surgery (PCO and YAG), Same-day vs one-eye-at-a-time surgery, and Diabetic eye exams in Seoul.


Nunehim Eye Center (눈에힘안과의원)
Head director: Dr. Daniel Jinhag Baik, MD, ophthalmologist
Address: 5F, 551 Siheung-daero, Guro-gu, Seoul (a 5-minute walk from Guro Digital Complex Station Exit 6, near Gasan Digital Complex)
Website: https://www.nunehim.com
One-on-one consultations in English with Dr. Baik

This article is general health education based on studies and guidelines available as of November 2026. It does not recommend any specific procedure, drug or device, does not guarantee results, and does not replace an individual examination. Surgical suitability is decided after an eye exam.

References

  1. Chu CJ, et al. Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes. Ophthalmology. 2016;123(2):316–323. https://pubmed.ncbi.nlm.nih.gov/26681390/
  2. Denniston AK, et al. The UK DR EMR Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema. Br J Ophthalmol. 2017;101(12):1673–1678. https://pubmed.ncbi.nlm.nih.gov/28487377/
  3. Lee SH, et al. Incidence and Progression of Diabetic Retinopathy After Cataract Surgery: A Systematic Review and Meta-Analysis. Am J Ophthalmol. 2025;269:105–115. https://pubmed.ncbi.nlm.nih.gov/39179126/
  4. Armbrust KR, et al. Preoperative Glycemic Control and Acute Endophthalmitis after Cataract Surgery in United States Veterans with Diabetes Mellitus. Ophthalmology. 2025;132(8):903–910. https://pubmed.ncbi.nlm.nih.gov/40122400/
  5. Hussain ZS, et al. Is There a Safe Glycemic Threshold for Cataract Surgery? Am J Ophthalmol. 2025;277:17–25. https://pubmed.ncbi.nlm.nih.gov/40324554/
  6. Hou CH, et al. Risk and dose-response relationship of diabetes mellitus for endophthalmitis after cataract surgery in a nationwide cohort study in Taiwan. Clin Exp Ophthalmol. 2023;51(7):692–703. https://pubmed.ncbi.nlm.nih.gov/37641488/
  7. Cui C, et al. The impact of diabetes mellitus and diabetic retinopathy on prognosis and complications after cataract surgery. Medicine (Baltimore). 2026;105(19):e48741. https://pubmed.ncbi.nlm.nih.gov/42116355/
  8. Wang Y, et al. Surgical Outcomes of Cataract Surgery Following Rapid Glycemic Control During Preoperative Period. Clin Ophthalmol. 2026. https://pubmed.ncbi.nlm.nih.gov/41847524/
  9. NICE. Cataracts in adults: management (NG77), recommendation 1.8.7. https://www.nice.org.uk/guidance/ng77/chapter/Recommendations
  10. Wielders LHP, et al. Prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2. J Cataract Refract Surg. 2018;44(7):836–847. https://pubmed.ncbi.nlm.nih.gov/30055692/
  11. Lim BX, et al. Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. Cochrane Database Syst Rev. 2016;11:CD006683. https://pubmed.ncbi.nlm.nih.gov/27801522/
  12. Laursen SB, et al. Prevention of macular edema in patients with diabetes after cataract surgery. J Cataract Refract Surg. 2019;45(6):854–869. https://pubmed.ncbi.nlm.nih.gov/31146934/
  13. Wu J, et al. Management after cataract surgery for patients with diabetic retinopathy: a systematic review and meta-analysis. Int Ophthalmol. 2024;44(1):166. https://pubmed.ncbi.nlm.nih.gov/38557801/
  14. Grzybowski A, et al. Multifocal intraocular lenses and retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2020;258(4):805–813. https://pubmed.ncbi.nlm.nih.gov/31955239/
  15. Liu X, et al. Multifocal intraocular lenses improve near vision but increase optical aberrations in patients with non-proliferative diabetic retinopathy. Am J Transl Res. 2025;17(7):5045–5053. https://pubmed.ncbi.nlm.nih.gov/40821032/

Leave a Reply